Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Depreciation & Amortization (CF) (2019 - 2026)

Atea Pharmaceuticals' Depreciation & Amortization (CF) history spans 8 years, with the latest figure at $104000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) changed 0.0% to $104000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $416000.0 through Mar 2026, changed 0.0% year-over-year, with the annual reading at $416000.0 for FY2025, 0.0% changed from the prior year.
  • Depreciation & Amortization (CF) came in at $104000.0 for Q1 2026, roughly flat from $104000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $106000.0 in Q3 2022 to a low of $7000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $104000.0 (2022), against an average of $94823.5.
  • Year-over-year, Depreciation & Amortization (CF) soared 1414.29% in 2022 and then fell 1.89% in 2023.
  • Atea Pharmaceuticals' Depreciation & Amortization (CF) stood at $104000.0 in 2022, then changed by 0.0% to $104000.0 in 2023, then changed by 0.0% to $104000.0 in 2024, then changed by 0.0% to $104000.0 in 2025, then changed by 0.0% to $104000.0 in 2026.
  • Per Business Quant, the three most recent readings for AVIR's Depreciation & Amortization (CF) are $104000.0 (Q1 2026), $104000.0 (Q4 2025), and $104000.0 (Q3 2025).